logo

Intellia Therapeutics, Inc. (NTLA)



Trade NTLA now with
  Date
  Headline
9/10/2018 7:02:53 AM F-star Appoints Nessan Bermingham As Chairman Of Board Of Directors
8/2/2018 10:08:57 AM Wedbush Is Increasing Intellia Therapeutics, Inc. (NTLA) FY18 Rev. Estimate To 38.6 M From 33.5 M
8/2/2018 10:08:35 AM Wedbush Is Increasing Intellia Therapeutics, Inc. (NTLA) FY18 Estimate To -2.00 From -2.12
8/2/2018 10:08:03 AM Wedbush Is Raising Intellia Therapeutics, Inc. (NTLA) Q3 18 Estimate To -0.57 From -0.62
8/1/2018 7:48:23 AM Intellia Therapeutics Q2 Net Loss $22.2 Mln Or $0.52/Shr Vs Loss $15.6 Mln Or $0.45/Shr Last Year
6/19/2018 9:10:02 AM CRISPR, Intellia Therapeutics And Caribou Biosciences Announce Grant Of US Patent For CRISPR/Cas9 Genome Editing
5/18/2018 7:25:49 AM Wedbush Reiterates Intellia Therapeutics, Inc. (NTLA) At Outperform With $36 Price Target
5/17/2018 7:33:37 AM Intellia Therapeutics Announces WT1 As Its First Cell Therapy Target
5/14/2018 7:34:27 AM New Scientific Advisors Focused On Cell Therapy In Immuno-Oncology And Autoimmunity Join Intellia Therapeutics
5/3/2018 9:41:29 AM Wedbush Is Increasing Intellia Therapeutics, Inc. (NTLA) FY18 Rev. Estimate To 33.5 M From 31.0 M
5/3/2018 9:41:05 AM Wedbush Is Raising Intellia Therapeutics, Inc. (NTLA) FY18 Estimate To -2.12 From -2.49
5/3/2018 9:40:47 AM Wedbush Is Raising Intellia Therapeutics, Inc. (NTLA) Q4 18 Estimate To -0.40 From -0.48
5/3/2018 9:40:16 AM Wedbush Is Increasing Intellia Therapeutics, Inc. (NTLA) Q3 18 Estimate To -0.62 From -0.70
5/3/2018 9:40:00 AM Wedbush Is Increasing Intellia Therapeutics, Inc. (NTLA) Q2 18 Estimate To -0.59 From -0.67
5/1/2018 7:33:45 AM Intellia Therapeutics Posts Q1 Net Loss Of $21.36 Mln Or $0.51/share
3/15/2018 7:28:55 AM Wedbush Is Lowering Intellia Therapeutics, Inc. (NTLA) FY18 Rev. Estimate To 31.0 M From 42.0 M
3/15/2018 7:28:43 AM Wedbush Is Cutting Intellia Therapeutics, Inc. (NTLA) Q3 18 Rev. Estimate To 5.0 M From 16.0 M
3/15/2018 7:28:17 AM Wedbush Is Cutting Intellia Therapeutics, Inc. (NTLA) FY18 Estimate To -2.49 From -1.75
3/15/2018 7:27:35 AM Wedbush Is Cutting Intellia Therapeutics, Inc. (NTLA) Q4 18 Estimate To -0.48 From -0.33
3/15/2018 7:27:20 AM Wedbush Is Cutting Intellia Therapeutics, Inc. (NTLA) Q3 18 Estimate To -0.70 From -0.30